A detailed history of Cornerstone Investment Partners, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Cornerstone Investment Partners, LLC holds 7,234 shares of VCYT stock, worth $293,555. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,234
Holding current value
$293,555
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$21.0 - $35.25 $151,914 - $254,998
7,234 New
7,234 $246,000
Q1 2020

Apr 27, 2020

SELL
$16.13 - $30.17 $143,476 - $268,362
-8,895 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$20.78 - $29.99 $184,838 - $266,761
8,895 New
8,895 $248,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.9B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.